Health FDA Approves SYFOVRE™ (pegcetacoplan injection) as the First and Only Treatment for Geographic Atrophy (GA), a Leading Cause of Blindness By Globe News Wire On Feb 18, 2023 35 Share A Media Snippet accompanying this announcement is available by clicking on the image or link below: Apellis PharmaceuticalsApprovesAtrophyBlindnessFDA 35 Share
